Login to Your Account

Pharma: Other News To Note

Thursday, February 23, 2012

• Shire plc, of Dublin, Ireland, said the European Committee for Medicinal Products for Human Use approved the production of Vpriv (velaglucerase alfa) in the firm's new manufacturing facility in Lexington, Mass. The European Commission's decision is expected shortly. Vpriv is an enzyme replacement therapy marketed for Gaucher disease.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription